Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Simon

Showing results (131-140 of 184) with videos related to

Pageof 19
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2010
Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastomaRoger Stupp, Monika E Hegi, Bart Neyns, et al.
Acta Neuropathologica|January 9, 2016
Erratum to: Gliomatosis cerebri: no evidence for a separate brain tumor entityUlrich Herrlinger, David T W Jones, Martin Glas, et al.
Neuro-Oncology|June 19, 2023
Individual glioblastoma cells harbor both proliferative and invasive capabilities during tumor progressionMiriam Ratliff, Kianush Karimian-Jazi, Dirk C Hoffmann, et al.
Acta Neuropathologica|November 19, 2021
DNA methylation-based classification of malformations of cortical development in the human brainSamir Jabari, Katja Kobow, Tom Pieper, et al.
Acta Neuropathologica|October 9, 2025
Tumor-associated macrophages in meningiomas: a novel biomarker for poor survival outperforming the benefits of T cellsCatharina Lotsch, Rolf Warta, Fang Liu, et al.
Frontiers in Genetics|October 24, 2012
Leveraging ethnic group incidence variation to investigate genetic susceptibility to glioma: a novel candidate SNP approachDaniel I Jacobs, Kyle M Walsh, Margaret Wrensch, et al.
Journal of Neuro-Oncology|July 7, 2022
Mid-term treatment-related cognitive sequelae in glioma patientsSabine Schlömer, Jörg Felsberg, Milena Pertz, et al.
The Lancet. Oncology|September 7, 2019
Health-related quality of life and neurocognitive functioning with lomustine-temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trialJohannes Weller, Theophilos Tzaridis, Frederic Mack, et al.
Journal of Neuro-Oncology|August 30, 2023
Long-term neurocognitive function and quality of life after multimodal therapy in adult glioma patients: a prospective long-term follow-upMilena Pertz, Sabine Schlömer, Clemens Seidel, et al.
Acta Neuropathologica|April 12, 2013
Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 proteinLeonille Schweizer, Christian Koelsche, Felix Sahm, et al.
Pageof 19

Showing results (131-140 of 184) with videos related to

Sort By:
Pageof 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2010
Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastomaRoger Stupp, Monika E Hegi, Bart Neyns, et al.
Acta Neuropathologica|January 9, 2016
Erratum to: Gliomatosis cerebri: no evidence for a separate brain tumor entityUlrich Herrlinger, David T W Jones, Martin Glas, et al.
Neuro-Oncology|June 19, 2023
Individual glioblastoma cells harbor both proliferative and invasive capabilities during tumor progressionMiriam Ratliff, Kianush Karimian-Jazi, Dirk C Hoffmann, et al.
Acta Neuropathologica|November 19, 2021
DNA methylation-based classification of malformations of cortical development in the human brainSamir Jabari, Katja Kobow, Tom Pieper, et al.
Acta Neuropathologica|October 9, 2025
Tumor-associated macrophages in meningiomas: a novel biomarker for poor survival outperforming the benefits of T cellsCatharina Lotsch, Rolf Warta, Fang Liu, et al.
Frontiers in Genetics|October 24, 2012
Leveraging ethnic group incidence variation to investigate genetic susceptibility to glioma: a novel candidate SNP approachDaniel I Jacobs, Kyle M Walsh, Margaret Wrensch, et al.
Journal of Neuro-Oncology|July 7, 2022
Mid-term treatment-related cognitive sequelae in glioma patientsSabine Schlömer, Jörg Felsberg, Milena Pertz, et al.
The Lancet. Oncology|September 7, 2019
Health-related quality of life and neurocognitive functioning with lomustine-temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trialJohannes Weller, Theophilos Tzaridis, Frederic Mack, et al.
Journal of Neuro-Oncology|August 30, 2023
Long-term neurocognitive function and quality of life after multimodal therapy in adult glioma patients: a prospective long-term follow-upMilena Pertz, Sabine Schlömer, Clemens Seidel, et al.
Acta Neuropathologica|April 12, 2013
Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 proteinLeonille Schweizer, Christian Koelsche, Felix Sahm, et al.
Pageof 19